Brief: Caladrius Biosciences Reports Second Quarter 2022 Financial Results And Provides Business Update
04/08/2022 23:04
Aug 4 (Reuters) - Caladrius Biosciences Inc CLBS.O :
* CALADRIUS BIOSCIENCES REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* CALADRIUS BIOSCIENCES INC - QTRLY LOSS PER SHARE $0.11
Source text for Eikon: ID:nGNX4PgWBL
Further company coverage: CLBS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Lisata Therapeutics Announces New Method Of Use Patent Granted For Certepetide In The Treatment Of Pancreatic Cancer And Other Solid Tumors
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE -Expeditors International, Waters, Ameresco